|
Pulmonary Edema
|
D011654 |
[Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.
] |
|
Pulmonary Elimination
|
D066232 |
[The discharge of substances from the pulmonary capillary blood into the alveolar space to be exhaled or removed by MUCOCILIARY CLEARANCE.
] |
|
Pulmonary Embolism
|
D011655 |
[Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
] |
|
Pulmonary Emphysema
|
D011656 |
[Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.
] |
|
Pulmonary Eosinophilia
|
D011657 |
[A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
, Pulmonary eosinophilia or pneumonia caused by parasitic infections in tropical areas .
] |
|
Pulmonary Fibrosis
|
D011658 |
[A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
] |
|
Pulmonary Gas Exchange
|
D011659 |
[The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER.
] |
|
Pulmonary Heart Disease
|
D011660 |
[Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM.
] |
|
Pulmonary Infarction
|
D054060 |
[NECROSIS of lung tissue that is cause by the lack of OXYGEN or blood supply. The most common cause of pulmonary infarction is a blood clot in the lung.
] |
|
Pulmonary Medicine
|
D015272 |
[A subspecialty of internal medicine concerned with the study of the RESPIRATORY SYSTEM. It is especially concerned with diagnosis and treatment of diseases and defects of the lungs and bronchial tree.
] |
|
Pulmonary Sclerosing Hemangioma
|
D047868 |
[A benign neoplasm of pneumocytes, cells of the PULMONARY ALVEOLI. Originally considered to be vascular in origin, it is now classified as an epithelial tumor with several elements, including solid cellular areas, papillary structure, sclerotic regions, and dilated blood-filled spaces resembling HEMANGIOMA.
] |
|
Pulmonary Stretch Receptors
|
D011661 |
[Stretch receptors found in the bronchi and bronchioles. Pulmonary stretch receptors are sensors for a reflex which stops inspiration. In humans, the reflex is protective and is probably not activated during normal respiration.
] |
|
Pulmonary Subvalvular Stenosis
|
D011662 |
[Narrowing below the PULMONARY VALVE or well below it in the infundibuluar chamber where the pulmonary artery originates, usually caused by a defective VENTRICULAR SEPTUM or presence of fibrous tissues. It is characterized by restricted blood outflow from the RIGHT VENTRICLE into the PULMONARY ARTERY, exertional fatigue, DYSPNEA, and chest discomfort.
] |
|
Pulmonary Surfactant-Associated Protein A
|
D037662 |
[An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens, resulting in their opsinization. It also stimulates MACROPHAGES to undergo PHAGOCYTOSIS of microorganisms. Surfactant protein A contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.
] |
|
Pulmonary Surfactant-Associated Protein B
|
D037701 |
[A pulmonary surfactant associated-protein that plays an essential role in alveolar stability by lowering the surface tension at the air-liquid interface. Inherited deficiency of pulmonary surfactant-associated protein B is one cause of RESPIRATORY DISTRESS SYNDROME, NEWBORN.
] |
|
Pulmonary Surfactant-Associated Protein C
|
D037721 |
[A pulmonary surfactant associated protein that plays a role in alveolar stability by lowering the surface tension at the air-liquid interface. It is a membrane-bound protein that constitutes 1-2% of the pulmonary surfactant mass. Pulmonary surfactant-associated protein C is one of the most hydrophobic peptides yet isolated and contains an alpha-helical domain with a central poly-valine segment that binds to phospholipid bilayers.
] |
|
Pulmonary Surfactant-Associated Protein D
|
D037663 |
[An abundant pulmonary surfactant-associated protein that binds to a variety of lung pathogens and enhances their opsinization and killing by phagocytic cells. Surfactant protein D contains a N-terminal collagen-like domain and a C-terminal lectin domain that are characteristic of members of the collectin family of proteins.
] |
|
Pulmonary Surfactant-Associated Proteins
|
D037661 |
[Proteins found in the LUNG that act as PULMONARY SURFACTANTS.
] |
|
Pulmonary Surfactants
|
D011663 |
[Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
] |
|
Pulmonary Surgical Procedures
|
D013510 |
[Surgery performed on the lung.
] |